logo

For the Inventor, By the Inventor

Seoul, South Korea

Chang Hyun Oh

This inventor holds 16 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: J & L Importers, Inc., Korea Institute of Science and Technology, Korea Research Institute of Bioscience and Biotechnology. Active years: 1985-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chang Hyun Oh. Retrieved from https://idiyas.com/inventor/chang-hyun-oh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 75.0

 

Average Co-Inventor Count = 1.6

ph-index = 7

Forward Citations = 133(Granted Patents)


Location History:

  • Kyung Ki Do, KR (1987)
  • Seoul, KR (1985 - 2022)

Company Filing History:

goldMedal9 out of 9 
 
J & L Importers, Inc.
 patents
silverMedal7 out of 2,248 
 
Korea Institute of Science and Technology
 patents
bronzeMedal1 out of 334 
 
Korea Research Institute of Bioscience and Biotechnology
 patents
4. 1 out of 654 
 
Korea Research Institute of Chemical Technology
 patents
where one patent can have more than one assignee

Years Active: 1985-2022

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 11332479 - Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same (2022-05-17),
2. 10570155 - Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same (2020-02-25),
3. 8765749 - 1,6-disubstituted indole compounds as protein kinase inhibitors (2014-07-01),
4. 8754209 - Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient (2014-06-17),
5. 8329708 - 1,3,6-substituted indole derivatives having inhibitory activity for protein kinase (2012-12-11),
6. 8273880 - Pyrazole compounds with inhibitory activity against ROS kinase (2012-09-25),
7. 8168797 - Oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient (2012-05-01),
8. D292472 - Fry pan or similar article (1987-10-27),
9. D292471 - Cooking utensil or similar article (1987-10-27),
10. D292470 - Fry pan or similar article (1987-10-27),
11. D292363 - Fry pan or similar article (1987-10-20),
12. D292362 - Cooking utensil or similar article (1987-10-20),
13. D292165 - Fry pan or similar article (1987-10-06),
14. D292164 - Fry pan or similar article (1987-10-06),
15. 4622948 - Cookware having integrally formed natural stone bottoms and method of (1986-11-18),

Title: Chang Hyun Oh: Innovator in Antitumor Pharmaceutical Compositions

Introduction

Chang Hyun Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with antitumor effects. With a total of 16 patents to his name, his work has the potential to impact cancer treatment significantly.

Latest Patents

One of Chang Hyun Oh's latest patents is an imidazooxazole derivative that exhibits antitumor effects. This pharmaceutical composition is designed for preventing and treating tumors. It includes an imidazooxazole derivative compound, a solvate, a stereoisomer, or a pharmaceutically acceptable salt as an active ingredient. The composition is administered to individuals who have developed a tumor or are at risk of developing one, thereby providing a means to prevent or treat tumors effectively.

Career Highlights

Throughout his career, Chang Hyun Oh has worked with notable organizations, including J & L Importers, Inc. and the Korea Institute of Science and Technology. His experience in these institutions has allowed him to refine his research and development skills, contributing to his success as an inventor.

Collaborations

Chang Hyun Oh has collaborated with several professionals in his field, including Kyung Ho Yoo and Tae Bo Sim. These collaborations have likely enhanced his research and led to innovative solutions in pharmaceutical development.

Conclusion

Chang Hyun Oh stands out as a significant figure in the realm of pharmaceutical innovation, particularly in the development of antitumor agents. His contributions through patents and collaborations continue to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…